Roche's lung cancer drug wins U.S. approval

… . health regulators as a second-line lung cancer
treatment, a decision seen likely …
be used in non-small cell lung cancer patients previously
treated with chemotherapy … in combination with other drugs.
Lung cancer, responsible for 20 percent of …